Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug unified coding rule management method and code identifier taking medical insurance payment as core

A management method and drug technology, applied in the field of information processing, can solve problems such as ununiform coding of business departments and systems, lack of coding rules, traceability, etc., to achieve the effect of promoting sharing and communication, and facilitating mutual transfer

Pending Publication Date: 2018-11-06
厦门海西医药交易中心有限公司
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing drug codes cannot achieve timely and effective traceability of all links in the whole process, and cannot meet the needs of comprehensive supervision of business data in all systems (circulation supervision, use supervision, medical insurance reimbursement supervision, etc.), and the content of information adjustments cannot be updated and released in a timely manner. The implementation progress of the area cannot be unified, causing the following problems to exist for a long time:
[0003] 1. The current coding system does not judge the uniqueness of enterprises / products: in the existing codes, there are multiple codes for one factory, multiple codes for one drug, and multiple uses for one code position
[0004] 2. The coding of each business department and system is not unified: At present, the coding of each system is not unified, and it is impossible to achieve timely and effective traceability of all links in the whole process, and timely update and release of content that needs to be adjusted
[0005] 3. The current drug coding cannot support the principle of four universals and three categories: four universals (requiring independent coding of generic name, generic dosage form, generic specifications, and generic packaging and supporting policy rules), and three categories (treatment, nutrition, auxiliary) are not applied Drug selection and pricing decisions
[0006] 4. The current business process cannot take into account the needs of various departments: medicinal collection and medical institution transactions expect the adjustment information to be updated from time to time; the settlement terminal of the medical insurance center involves multi-system data interaction, and it is expected to regularly specify a certain time for multi-system maintenance before execution
The current business process spans many departments for a long time, and further timeliness specification requirements have not been formed in the process of exploration and coordination
[0007] 5. Multi-department letter communication is required, and the medical insurance code is manually maintained: According to the existing coding business process, each change of the drug medical insurance code is issued through the province, and manual maintenance is performed twice in various places. Each update costs the province and the land A lot of energy from relevant people in the city
[0008] The source of the above-mentioned problems can be traced back to the inconsistency in the naming of various drugs in different management or query systems about pharmaceutical products, and the inability to communicate directly between various systems, which brings great pressure to the management and query of the entire pharmaceutical industry. There are great limitations, resulting in the lack of unified coding rules for drug procurement informatization centered on medical insurance payment and settlement, and the inability to realize whole-process supervision

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug unified coding rule management method and code identifier taking medical insurance payment as core
  • Drug unified coding rule management method and code identifier taking medical insurance payment as core
  • Drug unified coding rule management method and code identifier taking medical insurance payment as core

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Such as figure 1 As shown, a unified drug coding rule, management method and code recognizer with medical insurance payment as the core, including the following steps,

[0055] Step 1, enterprise information certification: drug production enterprises submit valid qualifications, and the drug trading platform conducts key qualification certification. Pharmaceutical production enterprises that meet the qualification requirements obtain a unique 6-digit enterprise code, and can maintain enterprise information and drug information through the platform.

[0056] Step 2, drug information maintenance: drug manufacturers maintain enterprise information and drug information through the drug trading platform, and provide necessary qualification support for the maintained information.

[0057] Step 3: Adjustment of listing information: The drug trading platform conducts certification according to the drug information provided by the drug manufacturer, confirms whether it meets th...

Embodiment 2

[0065] Such as figure 2 As shown, a kind of Chinese medicine (Zhibitai Capsule) is selected to encode, and the encoding is:

[0066] 1-2-1-Z0100-1-A1A8-10-1-0-1-0-G-510205-3-021-01-01-0

[0067] Among them, 1-2-1 represents medical insurance, OTC attribute RX, treatment; Z0100 represents the common name of traditional Chinese medicine, oral preparation of compound red yeast rice; 1-A1A8-10 represents the general dosage form is oral, the general specification is 0.24g, and the general packaging is 10 Tablets / box; 1-0-1-0 represents competition, no special certification, low-priced drugs, non-essential drugs; G-510205 represents domestic production, Chengdu Di’ao Jiuhong Pharmaceutical Factory, full marks for contract performance; 3-021-01- 01-0, representing non-sustained and controlled release, capsule, hydrochloride, packaging material is 01 attribute, no special drug attribute.

Embodiment 3

[0069] Such as figure 2 Shown, choose a kind of western medicine (roxithromycin sheet) to encode, and be encoded as:

[0070] 1-2-1-X0709-1-A792-10-1-0-1-0-G-311619-3-011-00-01-0

[0071] Among them, 1-2-1 represents medical insurance, OTC attribute RX, treatment; X0709 represents the generic name of western medicine, roxithromycin; 1-A792-10 represents the general dosage form is oral, the general specification is 50mg, and the general packaging is 10 tablets / Box; 1-0-1-0 represents competition, no special certification, low-priced drugs, non-essential drugs; G-311619 represents domestic production, Shanghai Modern Pharmaceutical Co., Ltd., full marks for performance; 3-011-00-01-0 , stands for non-sustained and controlled release, tablet / film-coated tablet, no acid radical, packaging material is 01 attribute, no special drug attribute.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug unified coding rule management method and a code identifier taking medical insurance payment as a core. Medical insurance payment service attribute information is comprised; the problem that one code is multipurpose is solved; on one hand, medical insurance codes are put forward, and medical insurance coding and approving requirements can be met in a code generationprocess; and on the other hand, a mode of performing pushing by a system and automatically adjusting code information is adopted, data expression standards are unified, a standard dosage form codingsystem, a specification expression model which can be refined and split, four-layer pharmacological classification refined layer by layer according to pharmacological effects, and market access information associated all the time crate a basic condition for drug grouping and price comparison, and a current medical insurance settlement service is satisfied. The invention provides the handheld wireless code identifier. A drugstore and a consumer can use the identifier to scan a drug barcode on a drug package, so that basic information of a drug can be viewed through a display screen embedded ina handle, and whether the drug is applicable or not can be judged conveniently.

Description

technical field [0001] The invention belongs to the technical field of information processing, and in particular relates to a drug uniform coding rule, a management method and a code recognizer with medical insurance payment as the core. Background technique [0002] With the advancement of the national medical insurance reform, the joint procurement of drugs, drug transactions, and medical insurance payment are becoming more and more closely related, and data exchanges between different systems are frequent. A general-purpose system that can meet the entire process of drug circulation and meet the needs of various departments of medical insurance Coding method for managing requirements. However, the drug standard code issued by the State Food and Drug Administration in 2009 mainly meets the needs of drug production management and circulation, and lacks an effective coding system to support the organization of effective drug management by provincial medical insurance departm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G06F17/30G06K7/10G06K17/00G16H40/20
CPCG06K7/10861G06K7/10881G06K17/00G16H40/20
Inventor 张锦聪罗聃吴燕
Owner 厦门海西医药交易中心有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products